Trupanion (TRUP) Panoramica del titolo
Trupanion, Inc., insieme alle sue controllate, offre assicurazioni sanitarie per cani e gatti con formula di abbonamento negli Stati Uniti, in Canada e nell'Europa continentale. Maggiori dettagli
| Punteggio fiocco di neve | |
|---|---|
| Valutazione | 0/6 |
| Crescita futura | 1/6 |
| Prestazioni passate | 2/6 |
| Salute finanziaria | 4/6 |
| Dividendi | 0/6 |
TRUP Community Fair Values
Create NarrativeSee what 7 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Concorrenti di Trupanion, Inc.
Storia dei prezzi e prestazioni
| Prezzi storici delle azioni | |
|---|---|
| Prezzo attuale dell'azione | US$26.35 |
| Massimo di 52 settimane | US$57.00 |
| Minimo di 52 settimane | US$21.16 |
| Beta | 1.39 |
| Variazione di 1 mese | 7.82% |
| Variazione a 3 mesi | -6.56% |
| Variazione di 1 anno | -48.06% |
| Variazione a 3 anni | 4.56% |
| Variazione a 5 anni | -76.52% |
| Variazione dall'IPO | 131.14% |
Notizie e aggiornamenti recenti
Aggiornamento narrativa • Jul 15
TRUP: Lower Catastrophe Exposure Will Support Long-Term Repricing Potential
For Trupanion, the analyst price target in this narrative framework has shifted lower from $52.00 to $45.00. This reflects analyst adjustments to long term revenue growth, profit margin expectations, and the future P/E multiple following recent catastrophe related commentary.
Aggiornamento narrativa • Jun 30
TRUP: Loyalty And Margin Execution Will Shape Prospective Earnings Upside
Trupanion's updated analyst price target has moved from $31.00 to $28.00 as analysts factor in slightly higher discount rates, a more moderate revenue growth outlook, and an adjusted future P/E assumption, while also reflecting recent Street target cuts. Analyst Commentary Recent Street commentary on Trupanion reflects a more cautious tone, with several bearish analysts trimming price targets and reassessing assumptions around growth, valuation, and execution risk.Aggiornamento narrativa • Jun 16
TRUP: Recalibrated Expectations And Improved Margins Will Support Long-Term Repricing
Trupanion's analyst price target has been reduced by $7 to $45. Analysts attribute the revision to updated assumptions around revenue growth, profit margins and future P/E multiples.
Aggiornamento narrativa • Jun 01
TRUP: Rebased P/E And Margin Assumptions Will Support Long Term Upside
Trupanion's analyst price target is updated from $46.25 to $39.75 as analysts factor in refreshed assumptions around discount rates, revenue growth, profit margins, and future P/E expectations, reflected in recent Street research cuts from BofA, Cantor Fitzgerald, and Stifel. Analyst Commentary Recent Street research indicates that the lower price targets are tied to refreshed assumptions around discount rates, revenue growth, profit margins, and future P/E expectations.Recent updates
Aggiornamento narrativa • Jul 15
TRUP: Lower Catastrophe Exposure Will Support Long-Term Repricing Potential
For Trupanion, the analyst price target in this narrative framework has shifted lower from $52.00 to $45.00. This reflects analyst adjustments to long term revenue growth, profit margin expectations, and the future P/E multiple following recent catastrophe related commentary.Aggiornamento narrativa • Jun 30
TRUP: Loyalty And Margin Execution Will Shape Prospective Earnings Upside
Trupanion's updated analyst price target has moved from $31.00 to $28.00 as analysts factor in slightly higher discount rates, a more moderate revenue growth outlook, and an adjusted future P/E assumption, while also reflecting recent Street target cuts. Analyst Commentary Recent Street commentary on Trupanion reflects a more cautious tone, with several bearish analysts trimming price targets and reassessing assumptions around growth, valuation, and execution risk.Aggiornamento narrativa • Jun 16
TRUP: Recalibrated Expectations And Improved Margins Will Support Long-Term Repricing
Trupanion's analyst price target has been reduced by $7 to $45. Analysts attribute the revision to updated assumptions around revenue growth, profit margins and future P/E multiples.Aggiornamento narrativa • Jun 01
TRUP: Rebased P/E And Margin Assumptions Will Support Long Term Upside
Trupanion's analyst price target is updated from $46.25 to $39.75 as analysts factor in refreshed assumptions around discount rates, revenue growth, profit margins, and future P/E expectations, reflected in recent Street research cuts from BofA, Cantor Fitzgerald, and Stifel. Analyst Commentary Recent Street research indicates that the lower price targets are tied to refreshed assumptions around discount rates, revenue growth, profit margins, and future P/E expectations.Seeking Alpha • May 26
Trupanion: The Stock Has De-Rated, But The Problems Haven't
Summary Trupanion maintains respectable revenue growth and record subscription margins, but growth is driven by price increases, not pet enrollment. Pet enrollment continues at a sluggish 5% annual rate, while customer acquisition costs and veterinary inflation outpace revenue growth, pressuring unit economics. Management's digital-first product launch targets younger demographics but carries high execution risk and is unlikely to materially impact 2026 results. Despite a strong balance sheet and lower valuation, TRUP's core growth and competitive challenges justify maintaining a sell rating. Read the full article on Seeking AlphaAggiornamento narrativa • May 13
TRUP: Recalibrated Expectations And Higher Future P/E Will Support Long-Term Repricing
Analysts have lowered their fair value estimate for Trupanion from $63.00 to $52.00, citing updated price targets from several firms along with adjustments to discount rates, revenue growth, profit margin assumptions, and the stock's future P/E multiple. Analyst Commentary Recent Street research on Trupanion has centered on revised price targets that reflect updated assumptions for growth, margins, and valuation multiples.Aggiornamento narrativa • Apr 22
TRUP: Clustered Price Cuts And P/E Reset Will Shape Future Returns
Trupanion's updated analyst price target has been reduced by a mid single digit dollar amount, with analysts pointing to recently lowered targets from several firms, alongside only modest tweaks to long term revenue growth, profit margin and future P/E assumptions. Analyst Commentary Recent Street research on Trupanion has centered on a series of price target reductions, with cuts ranging from low single digit dollar amounts up to a $15 move.Aggiornamento narrativa • Apr 08
TRUP: Revised P/E And Margin Assumptions Will Support Future Earnings Power
Trupanion's updated analyst price target has shifted from $42.00 to $31.00 as analysts factor in different assumptions for future revenue growth, profitability and P/E expectations following several recent target cuts across the Street. Analyst Commentary Recent Street research on Trupanion has centered on a series of lower price targets, with several bearish analysts trimming their expectations within a relatively short time frame.Aggiornamento narrativa • Mar 25
TRUP: Rebased P/E Expectations Will Support Long Term Upside Potential
Narrative Update on Trupanion The analyst price target for Trupanion has been reduced by a combined $26, as several firms revisited their models and pricing assumptions. This led to a lower implied future P/E while keeping the fair value estimate steady at $46.25.Aggiornamento narrativa • Mar 10
TRUP: Reset Expectations And Higher Future P/E Will Drive Long-Term Repricing
Trupanion's updated $63.0 analyst price target reflects modestly tempered expectations for revenue growth and profit margin, with analysts citing recent target reductions from several firms as they reassess the stock's risk and return trade off. Analyst Commentary Recent Street research on Trupanion clusters around lower price targets, but the tone is not uniformly negative.Aggiornamento narrativa • Feb 24
TRUP: Long Term Profitability Assumptions Will Support Future Upside Potential
Analysts have reduced their Trupanion price targets by approximately $10 to $46.25, reflecting updated views on fair value, discount rate, revenue growth, profit margin, and future P/E assumptions following recent research updates from multiple firms. Analyst Commentary Recent research updates on Trupanion point to a mix of optimism about the long term opportunity and caution about the execution and valuation risks in the near term.Aggiornamento narrativa • Feb 09
TRUP: Higher Future P/E Assumptions Will Support A Stronger Long-Term Repricing
Analysts have reduced their Trupanion price target by about $4 to US$63, citing updated assumptions around fair value, discount rate, revenue growth, profit margin and future P/E as the key drivers of the change. Analyst Commentary Bullish analysts are refining their views on Trupanion as they revisit key valuation inputs such as fair value estimates, discount rates, revenue assumptions, profit margins and future P/E levels.Aggiornamento narrativa • Jan 25
TRUP: Revised P/E Assumptions Will Support Long Term Earnings Power
Analysts have reduced their price targets on Trupanion by $8, citing updated assumptions for revenue growth, profit margin and future P/E, which modestly adjust the risk and return profile they see for the stock. Analyst Commentary Bearish analysts cutting their price targets by $8 are signaling a more cautious stance on Trupanion, driven by updated assumptions for revenue growth, profit margin and future P/E.Aggiornamento narrativa • Jan 11
TRUP: Future Margin Gains And Share Discipline Will Support Long Term Earnings Power
Analysts are maintaining a US$42.00 price target for Trupanion, with small adjustments to revenue growth, profit margin assumptions and a lower future P/E helping to fine tune their outlook rather than reset it. What's in the News Trupanion reported that, between July 1 and September 30, 2025, it did not repurchase any shares under its existing program and has completed total buybacks of 95,021 shares for US$5.75 million, representing 0.23% of shares under the buyback announced on April 30, 2021 (company filing).Aggiornamento narrativa • Dec 27
TRUP: Future Margin Expansion Will Support Strengthening Long Term Earnings Power
Analysts have modestly maintained their price target on Trupanion at approximately $42.00, citing slightly stronger expectations for revenue growth, incremental profit margin improvement, and a marginally lower future price to earnings multiple that together support the current valuation stance. What's in the News Updated full year 2025 guidance now calls for total revenue of $1.433 billion to $1.439 billion and subscription revenue of $986 million to $989 million, implying roughly 15% year over year subscription growth at the midpoint (company guidance).Aggiornamento narrativa • Dec 12
TRUP: Future Margin Recovery Will Support Strengthening Long Term Earnings Power
Analysts have modestly reduced their price target on Trupanion from 45.00 dollars to 42.00 dollars. This reflects more conservative assumptions for revenue growth, profit margins, and valuation multiples, despite a largely unchanged risk outlook.Aggiornamento narrativa • Aug 10
Increasing Pet Ownership And Data Analytics Will Expand Market
The consensus price target for Trupanion has increased to $59.67 as analysts assign a higher future P/E multiple despite a modest decline in net profit margin, signaling greater optimism about its growth prospects. Valuation Changes Summary of Valuation Changes for Trupanion The Consensus Analyst Price Target has significantly risen from $53.00 to $59.67.Nuova narrativa • May 27
Global Expansion And Pricing Precision Will Shape Pet Markets
Enhanced pricing strategies, technology upgrades, and disciplined underwriting are driving margin expansion, higher operational efficiency, and more sustainable long-term earnings.Articolo di analisi • May 13
Trupanion, Inc. (NASDAQ:TRUP) Looks Just Right With A 26% Price Jump
Trupanion, Inc. ( NASDAQ:TRUP ) shareholders are no doubt pleased to see that the share price has bounced 26% in the...Articolo di analisi • Feb 16
There's Reason For Concern Over Trupanion, Inc.'s (NASDAQ:TRUP) Price
When close to half the companies in the Insurance industry in the United States have price-to-sales ratios (or "P/S...Seeking Alpha • Dec 13
Trupanion: High Costs And Price Hikes Are Reasons To Avoid This Pet Insurer
Summary Trupanion's Q3'24 revenue grew 15% YoY to $327.5M, driven mainly by price hikes, but EPS missed estimates by $0.46. Subscription adjusted operating income surged 66% to $30.8M, improving margins, but new pet growth deceleration raises concerns. Expansion into Germany and Switzerland offers growth opportunities, but North American profitability and competitive pressures remain critical challenges. Trupanion faces risks from unsustainable price hikes, growing veterinary inflation, and higher acquisition costs. Its strategy of ramping up pet acquisition spending could pressure short-term profitability without guaranteeing long-term growth. Despite growth prospects in the pet insurance market, Trupanion’s high valuation, with an expected 7% revenue growth in 2025, makes it an expensive investment. Read the full article on Seeking AlphaArticolo di analisi • Oct 25
Revenues Tell The Story For Trupanion, Inc. (NASDAQ:TRUP) As Its Stock Soars 25%
Trupanion, Inc. ( NASDAQ:TRUP ) shares have continued their recent momentum with a 25% gain in the last month alone...Seeking Alpha • Sep 24
Trupanion: Great Business, But It Is Time To Cash Out (Rating Downgrade)
Summary Trupanion's stock surged over 60% since my June 2024 buy rating. Trupanion's Q2 results show strong revenue and subscription growth, with free cash flow turning positive, indicating a sustainable business model. Price hikes are essential due to rising veterinary costs and increasing anxiety claims in pets, which could impact long-term profitability if not managed. Shares are no longer a buy, and I reiterate my $40 price target with a hold rating now. Read the full article on Seeking AlphaArticolo di analisi • Aug 11
Trupanion, Inc. (NASDAQ:TRUP) Just Reported And Analysts Have Been Lifting Their Price Targets
It's been a pretty great week for Trupanion, Inc. ( NASDAQ:TRUP ) shareholders, with its shares surging 14% to US$38.30...Articolo di analisi • Jul 31
A Piece Of The Puzzle Missing From Trupanion, Inc.'s (NASDAQ:TRUP) 27% Share Price Climb
Trupanion, Inc. ( NASDAQ:TRUP ) shares have continued their recent momentum with a 27% gain in the last month alone...Seeking Alpha • Jun 13
Trupanion: Growth First, Profitability Second
Summary Trupanion is a global pet insurance company. Trupanion may be headed for profitability, with the new CEO emphasizing efficiency and free cash flow. The company offers pet insurance through subscriptions, focusing on growth first and profits later. Shares are a buy with a price target of $40. Read the full article on Seeking AlphaArticolo di analisi • Feb 16
A Piece Of The Puzzle Missing From Trupanion, Inc.'s (NASDAQ:TRUP) 27% Share Price Climb
Despite an already strong run, Trupanion, Inc. ( NASDAQ:TRUP ) shares have been powering on, with a gain of 27% in the...Seeking Alpha • Feb 02
Trupanion: After All This Time, No Profits
Summary Pet insurance industry has seen significant growth due to the rising trend of millennials and Gen Z preferring pets over having children. Trupanion, a pet insurance company, has experienced wild revenue growth but struggles with increasing costs and negative margins. The company's balance sheet is not heavily burdened with liabilities, but profitability hinges on stabilizing operating expenses and addressing veterinary price hikes. Read the full article on Seeking AlphaArticolo di analisi • Dec 18
A Piece Of The Puzzle Missing From Trupanion, Inc.'s (NASDAQ:TRUP) 27% Share Price Climb
Trupanion, Inc. ( NASDAQ:TRUP ) shares have had a really impressive month, gaining 27% after a shaky period beforehand...Articolo di analisi • Apr 18
What You Can Learn From Trupanion, Inc.'s (NASDAQ:TRUP) P/SAfter Its 35% Share Price Crash
The Trupanion, Inc. ( NASDAQ:TRUP ) share price has fared very poorly over the last month, falling by a substantial...Rendimenti per gli azionisti
| TRUP | US Insurance | US Mercato | |
|---|---|---|---|
| 7D | 2.0% | -0.5% | -0.9% |
| 1Y | -48.1% | 4.6% | 19.1% |
Ritorno vs Industria: TRUP ha avuto una performance inferiore rispetto al US Insurance che ha registrato un rendimento 4.6 % nell'ultimo anno.
Rendimento vs Mercato: TRUP ha avuto una performance inferiore al mercato US che ha registrato un rendimento 19.1 % nell'ultimo anno.
Volatilità dei prezzi
| TRUP volatility | |
|---|---|
| TRUP Average Weekly Movement | 6.6% |
| Insurance Industry Average Movement | 4.5% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.2% |
Prezzo delle azioni stabile: TRUP non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi rispetto al mercato US.
Volatilità nel tempo: La volatilità settimanale ( 7% ) di TRUP è rimasta stabile nell'ultimo anno.
Informazioni sull'azienda
| Fondato | I dipendenti | AMMINISTRATORE DELEGATO | Sito web |
|---|---|---|---|
| 2000 | 1,121 | Margi Tooth | www.trupanion.com |
Trupanion, Inc., insieme alle sue controllate, offre assicurazioni sanitarie per cani e gatti su base di abbonamento negli Stati Uniti, in Canada e nell’Europa continentale. La società opera in due segmenti: “Attività di abbonamento” e “Altre attività”. Si rivolge ai proprietari di animali da compagnia e ai veterinari.
Trupanion, Inc. Riepilogo dei fondamenti
| TRUP statistiche fondamentali | |
|---|---|
| Capitalizzazione di mercato | US$1.11b |
| Utili (TTM) | US$25.80m |
| Ricavi(TTM) | US$1.48b |
44.6x
Rapporto P/E0.8x
Rapporto P/STRUP è sopravvalutato?
Vedi Fair Value e analisi di valutazioneUtili e ricavi
| TRUP Conto economico (TTM) | |
|---|---|
| Ricavi | US$1.48b |
| Costo del fatturato | US$1.15b |
| Profitto lordo | US$330.92m |
| Altre spese | US$305.12m |
| Utili | US$25.80m |
Ultimi utili riportati
Mar 31, 2026
Prossima data di guadagno
n/a
| Utile per azione (EPS) | 0.59 |
| Margine lordo | 22.34% |
| Margine di profitto netto | 1.74% |
| Rapporto debito/patrimonio netto | 27.7% |
Come si è comportato TRUP nel lungo periodo?
Vedi performance storica e confrontoAnalisi aziendale e situazione dei dati finanziari
| Dati | Ultimo aggiornamento (ora UTC) |
|---|---|
| Analisi dell'azienda | 2026/07/16 04:46 |
| Prezzo dell'azione a fine giornata | 2026/07/16 00:00 |
| Utili | 2026/03/31 |
| Utili annuali | 2025/12/31 |
Fonti dei dati
I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.
| Pacchetto | Dati | Tempistica | Esempio Fonte USA * |
|---|---|---|---|
| Dati finanziari della società | 10 anni |
| |
| Stime di consenso degli analisti | +3 anni |
|
|
| Prezzi di mercato | 30 anni |
| |
| Proprietà | 10 anni |
| |
| Gestione | 10 anni |
| |
| Sviluppi principali | 10 anni |
|
* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.
Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.
Modello di analisi e Snowflake
I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina GitHub; abbiamo anche delle guide su come utilizzare i nostri report e dei tutorial su YouTube.
Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.
Metriche di settore e industriali
Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.
Fonti analitiche
Trupanion, Inc. è coperta da 16 analisti. 5 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.
| Analista | Istituzione |
|---|---|
| Christopher Merwin | Barclays |
| Joshua Shanker | BofA Global Research |
| Ryan Tunis | Cantor Fitzgerald & Co. |